Oxford Cancer Analytics - About the company
Oxford Cancer Analytics is a series A company based in Oxford (United Kingdom), founded in 2018 by Andreas Halner. It operates as a Provider of a platform for detection of lung cancer. Oxford Cancer Analytics has raised $16.5M in funding from investors like We Venture Capital, Eka Ventures and Cross Border Impact Ventures. The company has 42 active competitors, including 14 funded and 8 that have exited. Its top competitors include companies like Biodesix, OncoCyte and PrognomiQ.
Company Details
Provider of a platform for detection of lung cancer. The DEcancer is an AI-based platform that detects cancer through a blood test. It analyzes liquid biopsy results for DNA, protein, and epigenetics for detecting lung cancer.
Key Metrics
Founded Year
2018
Location
Oxford, United Kingdom
Stage
Series A
Total Funding
$16.5M in 3 rounds
Latest Funding Round
Investors
Ranked
7th among 42 active competitors
Employee Count
29 as on Aug 31, 2026
Legal entities associated with Oxford Cancer Analytics
Oxford Cancer Analytics is associated with 1 legal entity given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
OXFORD CANCER ANALYTICS LTD CIN: 12437885 , United Kingdom, Active | Feb 02, 2020 | - | 13 (As on Dec 31, 2024) |
Sign up to download Oxford Cancer Analytics' company profile
Oxford Cancer Analytics's funding and investors
Oxford Cancer Analytics has raised a total funding of $16.5M over 3 rounds. Its first funding round was on Sep 06, 2021. Its latest funding round was a Series A round on Jan 09, 2025 for $*****. 7 investors participated in its latest round. Oxford Cancer Analytics has 14 institutional investors.
Here is the list of recent funding rounds of Oxford Cancer Analytics:
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Jan 09, 2025 | 3932714 | Series A | 5310982 | 4054996 | 3156325 | 5554860 |
Jan 10, 2023 | 1159694 | Seed | 3836245 | 9469310 | 8150674 | |
Sep 06, 2021 | 4295790 | Seed | 1294459 | 2370191 | 6353970 |
Access funding benchmarks and valuations. Sign up today!View details of Oxford Cancer Analytics's funding rounds and investors
Oxford Cancer Analytics' founders and board of directors
Founder? Claim ProfileThe founders of Oxford Cancer Analytics is Andreas Halner.
Here are the details of Oxford Cancer Analytics' key team members:
- Andreas Halner: Founding CEO and Founder of Oxford Cancer Analytics.
View details of Oxford Cancer Analytics's Founder profiles and Board Members
Oxford Cancer Analytics' employee count trend
Oxford Cancer Analytics has 29 employees as of Aug 26. Here is Oxford Cancer Analytics's employee count trend over the years:
Uncover Oxford Cancer Analytics' growth story! Sign up today!
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Oxford Cancer Analytics's Competitors and alternates
Top competitors of Oxford Cancer Analytics include Biodesix, OncoCyte and PrognomiQ. Here is the list of Top 10 competitors of Oxford Cancer Analytics, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st |  Biodesix 2005, Boulder (United States), Public | Developer of diagnostics assays for the detection of cancer | $200M | 73/100 | |
2nd |  OncoCyte 2009, Irvine (United States), Public | Developer of non-invasive diagnostic tests solutions for the treatment of cancer | $15.3M | 66/100 | |
3rd | PrognomiQ 2020, San Mateo (United States), Series D | Developer of tests for the detection and treatment of cancer and other diseases | $135M | 63/100 | |
4th | Mursla 2017, London (United Kingdom), Seed | Provider of diagnostic device for cancer detection | $547K | 55/100 | |
5th | _1571830790831.png?devicePixelRatio=2&height=30&width=30){kind=logo} Biofidelity 2002, Cambridge (United Kingdom), Series B | Developer of a molecular diagnostic assay for the detection of target DNA sequences | $60M | 50/100 | |
6th | AI-based oncology therapy plan solution for professionals | $43M | 49/100 | ||
7th |  Oxford Cancer Analytics 2018, Oxford (United Kingdom), Series A | Provider of a platform for detection of lung cancer | $16.5M | 47/100 | |
8th | Cizzle Biotechnology 2005, York (United Kingdom), Public | Developer of blood tests for early lung cancer detection | $1.98M | 47/100 | |
9th | _1567753291263.png?devicePixelRatio=2&height=30&width=30){kind=logo} LungLife AI Thousand Oaks (United States), Public | Developer of an AI-enabled biomarker detection tests | $62.3M | 45/100 | |
10th | Hummingbird Diagnostics 2015, Heidelberg (Germany), Seed | Developer of blood tests integrating disease and immune response biomarkers | - | 44/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on Oxford Cancer Analytics's competitors? Click here to see the top ones
Oxford Cancer Analytics's Investments and acquisitions
Oxford Cancer Analytics has made no investments or acquisitions yet.
Reports related to Oxford Cancer Analytics
Here is the latest report on Oxford Cancer Analytics's sector:
News related to Oxford Cancer Analytics
•
Oxford Cancer Analytics brings in US$11m in Series A fundingThe Business Magazine•Aug 14, 2025•OKG Capital, We Venture Capital, Oxford Cancer Analytics, Impact Ventures and 5 others
•
We Venture Capital invests in medtech Oxford Cancer Analytics and Proton IntelligenceCapital-Riesgo.es•Mar 08, 2025•We Venture Capital, Oxford Cancer Analytics, Proton Intelligence, Cross Border Impact Ventures and 5 others
•
Oxford Cancer Analytics Raises USD$11M in Series A FundingFinSMEs•Jan 09, 2025•Oxford Cancer Analytics, We Venture Capital, Cross Border Impact Ventures, Eka Ventures and 6 others
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Are you a Founder ?
FAQs about Oxford Cancer Analytics
Explore our recently published companies
- Bobsyeruncle - 1999 founded, Unfunded company
- Judyannejackson - Unfunded company
- Flyhii - Hyderabad based, 2022 founded, Unfunded company
- Philonet - Bengaluru based, 2024 founded, Unfunded company
- Swasth Technologies - Bengaluru based, 2018 founded, Unfunded company
- Pallix - Pune based, 2026 founded, Unfunded company
